Lataa...
Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: A pharmaco‐economic assessment
OBJECTIVE: Autologous stem cell transplantation (ASCT) has improved progression‐free survival (PFS) and overall survival in eligible patients with newly diagnosed multiple myeloma (NDMM); however, relapse occurs. Maintenance therapy with lenalidomide (Len‐Mt) extends survival and delays relapse and...
Tallennettuna:
| Julkaisussa: | Eur J Haematol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590122/ https://ncbi.nlm.nih.gov/pubmed/32705720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13497 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|